Articles Tagged: State Attorneys General


Mifepristone Fights Keep FDA Power and State Authority on a Collision Course

Litigation over mifepristone is poised to remain one of the most closely watched legal battlegrounds of 2026, with challenges unfolding across multiple fronts at once: federal agency authority, state abortion restrictions, drug distribution rules, and preemption.